Monovisc 88 MG/4 ML syringe 4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F74WF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,609
Award facts
- Contract value 100% obligated
- $11,609.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 12, 2026, for Monovisc 88 mg/4 mL syringes with a ceiling value of $11,609.20. The order is issued under the DLA Troop Support Medical IDC, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026.
Place of performance is Conshohocken, PA. The ultimate completion date is February 13, 2026. Pricing is firm fixed price. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26F74WF?
SPE2DR26F74WF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 12, 2026.
How much is contract SPE2DR26F74WF worth?
The government has obligated $11,609 on SPE2DR26F74WF.
Is contract SPE2DR26F74WF an order under another contract?
Yes. SPE2DR26F74WF is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F74WF competed?
The extent of competition for SPE2DR26F74WF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award